Sugarlo Plus 50/1000 Mg 30 Tablets

Sugarlo Plus 50/1000 Mg 30 Tablets

Description:

Sugarlo Plus 50/1000 mg 30 tablets is an oral prescription antidiabetic medicine used in the management of type 2 diabetes mellitus. It combines two active ingredients, vildagliptin and metformin hydrochloride, to help control blood glucose levels when diet and exercise alone, or metformin alone, are not sufficient. Sugarlo Plus belongs to the class of DPP-4 inhibitors (vildagliptin) and biguanides (metformin), offering a dual mechanism of action that improves insulin response and reduces glucose production in the liver. It is intended for adult patients and should be used under medical supervision as part of a comprehensive diabetes care plan.

Indications:

• Type 2 diabetes mellitus (non–insulin-dependent diabetes) in adults.
• Used to improve glycemic control when metformin alone, along with diet and exercise, does not provide adequate blood sugar control.
• May be used as part of combination therapy in patients requiring dual oral therapy for better fasting and postprandial blood glucose management.
• Helps reduce elevated blood glucose levels and associated symptoms such as excessive thirst, frequent urination, and fatigue when used as prescribed.

Active Ingredients / Key Components:

• Vildagliptin – 50 mg per tablet (dipeptidyl peptidase-4 (DPP-4) inhibitor).
• Metformin hydrochloride – 1000 mg per tablet (biguanide oral antidiabetic).
• Other inactive ingredients/excipients: exact composition is not available in the provided information; refer to the package leaflet for full excipient list.

Dosage & Administration / How to Use:

• Use exactly as prescribed by your physician. Do not change your dose or stop the medicine without medical advice.
• Typical adult dose for this strength (50/1000 mg) is usually one tablet taken twice daily (morning and evening), with meals, but the exact regimen is determined by the doctor based on individual response and previous therapy.
• Tablets should be swallowed whole with water; do not crush or chew unless your doctor or pharmacist advises otherwise.
• Take Sugarlo Plus with food to reduce the risk of gastrointestinal side effects related to metformin (such as nausea or stomach upset).
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed tablet.
• Regular monitoring of blood glucose and, when indicated, HbA1c is recommended to assess treatment effectiveness.
• Your doctor may adjust the dose based on kidney function, liver function, age, and concomitant medications.

Clinical Benefits:

• Provides dual action blood sugar control by increasing insulin secretion in response to meals (vildagliptin) and reducing hepatic glucose production (metformin).
• Helps improve both fasting and postprandial (after-meal) blood glucose levels in adults with type 2 diabetes.
• Supports better long-term glycemic control (HbA1c reduction) when used regularly with diet and exercise.
• Metformin component may help improve lipid profile in type 2 diabetics, contributing to overall cardiometabolic health.
• May reduce the risk of diabetes-related complications when used as part of a comprehensive diabetes management plan, including lifestyle modifications and regular monitoring.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to vildagliptin, metformin, or any of the tablet components.
• Contraindicated in patients with severe renal impairment or significant reduction in kidney function, due to increased risk of lactic acidosis from metformin.
• Not recommended in patients with acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma.
• Use with caution in patients with liver impairment, heart failure, dehydration, severe infection, or conditions associated with hypoxia (e.g., recent myocardial infarction, respiratory failure).
• Metformin is associated with a rare but serious risk of lactic acidosis, especially in patients with kidney problems, advanced age, or conditions predisposing to hypoxia; seek immediate medical attention if you experience unexplained fatigue, muscle pain, breathing difficulty, abdominal pain, or feeling very unwell.
• Vildagliptin has been associated in rare cases with liver function abnormalities; periodic liver function tests may be recommended by your doctor.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Your doctor may switch you to insulin during pregnancy.
• Inform your doctor about all other medications you are taking, especially other antidiabetic drugs, diuretics, corticosteroids, contrast media containing iodine, or drugs affecting kidney or liver function.
• Alcohol intake should be limited or avoided, as it increases the risk of lactic acidosis with metformin.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision; it is a prescription medicine for confirmed type 2 diabetes.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, vomiting, diarrhea, abdominal discomfort, loss of appetite, or metallic taste (mainly related to metformin), and mild headache or dizziness.
• Some patients may experience low blood sugar (hypoglycemia), especially if Sugarlo Plus is used with other antidiabetic medicines such as sulfonylureas or insulin. Symptoms include sweating, shakiness, hunger, palpitations, and confusion.
• Vildagliptin has been rarely associated with liver enzyme elevations; symptoms of liver problems may include yellowing of the skin or eyes (jaundice), dark urine, or persistent abdominal pain.
• Very rare but serious side effect: lactic acidosis (a medical emergency) linked to metformin. Signs include rapid breathing, severe weakness, drowsiness, muscle pain, abdominal pain, and feeling very cold or unwell. Stop the medicine and seek urgent medical help if these occur.
• Allergic reactions such as rash, itching, swelling of the face, lips, or throat, or difficulty breathing require immediate medical attention.
• If any side effect persists, worsens, or you notice any unusual symptoms, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Product type: Oral antidiabetic medicine (prescription).
• Strength: 50 mg vildagliptin + 1000 mg metformin hydrochloride per tablet.
• Form: Film-coated tablets.
• Pack size: 30 tablets per pack.
• Intended use: Adult type 2 diabetes management as part of a complete treatment plan including diet and exercise.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.